Comparative Effectiveness of Intravenous Immunoglobulin for Children with Kawasaki Disease: A Nationwide Cohort Study | PLOS ONE
Late Treatment and Recurrence of Kawasaki Disease in a Moroccan Infant
Frontiers | Epidemiology of Kawasaki Disease in Europe
Rheumato | Free Full-Text | Kawasaki Disease: Management Challenges during COVID-19 Pandemic with an Upsurge in Multisystem Inflammatory Syndrome in Children
Kawasaki Disease
Clinical characteristics of patients with recurrent Kawasaki disease: a nationwide cohort study of 19 456 patients with minimum 3-year follow up | Archives of Disease in Childhood
Frontiers | How Should We Classify Kawasaki Disease?
Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study
Clinical Practice Guidelines : Kawasaki disease
Kawasaki Disease: Practice Essentials, Background, Pathophysiology
Kawasaki Disease
Is it Kawasaki Disease or Multisystem Inflammatory Syndrome in Children? - ScienceDirect
Clinical characteristics of patients with recurrent Kawasaki disease: a nationwide cohort study of 19 456 patients with minimum 3-year follow up | Archives of Disease in Childhood
Children | Free Full-Text | Recurrent Kawasaki Disease: A Case Report of Three Separate Episodes at >4-Year Intervals
Frontiers | Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne
Combination therapy reduces risk for abnormalities, treatment failure in Kawasaki disease
Recurrent Kawasaki disease and cardiac complications: nationwide surveys in Japan | Archives of Disease in Childhood
Long-term Consequences of Kawasaki Disease | Circulation
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
Frontiers | Increased Incidence of Kawasaki Disease in Taiwan in Recent Years: A 15 Years Nationwide Population-Based Cohort Study
Abstract 134: Early Immunoglogulin Therapy and Outcomes of Kawasaki Disease | Circulation
